RECENT APPROACHES FOR SODIUM-GLUCOSE CO-TRANSPORTER 2 INHIBITORS IN THE MANAGEMENT OF NON-ALCOHOLIC FATTY LIVER DISEASE

Reno Protective Effect of Sodium Glucose Cotransporter-2 Inhibitor (Dapagliflozin) in Type 2 Diabetic Patients

Unlocking Heart Failure's Secret Weapon: The Transformative Impact of Sodium-Glucose Cotransporter-2 Inhibitors on Heart Failure with Reduced Ejection Fraction

Potential mechanisms underlying the renoprotective effect of empagliflozin, a novel selective sodium glucose co-transporter (SGLT) 2 inhibitor, against diabetic nephropathy in st

Prevalence And Impact of Hyponatremia in Chronic Kidney Disease Patients with Coronavirus Disease 2019

Role of Fractional Sodium Excretion in patients with Refractory Hypertension

Safety and Tolerability of Sodium Glucose Co-Transporters-2 Inhibitors Among Elderly Patients with Type 2 Diabetes Fasting Ramadan

Possible Role of Increased Sodium Gradient on Intradialytic Hypertension Phenomenon

Dysnatremia in hospitalized elderly patients

The Reno-protective effect of SGLT-2 inhibitors in non-diabetic patients. A comparative review